1,4,7-triazacyclononane-n,n',n''-triacetic acid and pyrroles

1,4,7-triazacyclononane-n,n',n''-triacetic acid has been researched along with pyrroles in 1 studies

Compound Research Comparison

Studies (1,4,7-triazacyclononane-n,n',n''-triacetic acid)	Trials (1,4,7-triazacyclononane-n,n',n''-triacetic acid)	Recent Studies (post-2010) (1,4,7-triazacyclononane-n,n',n''-triacetic acid)	Studies (pyrroles)	Trials (pyrroles)	Recent Studies (post-2010) (pyrroles)
195	3	161	26,129	2,815	12,100

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barnhart, TE; Cai, W; Chakravarty, R; Chen, F; Goel, S; Hernandez, R; Hong, H; Valdovinos, HF	1

Other Studies

1 other study(ies) available for 1,4,7-triazacyclononane-n,n',n''-triacetic acid and pyrroles

Article	Year
Hollow mesoporous silica nanoparticles for tumor vasculature targeting and PET image-guided drug delivery. Nanomedicine (London, England), 2015, Volume: 10, Issue:8 Topics: Angiogenesis Inhibitors; Animals; Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Female; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Indoles; Mice, Nude; Nanoparticles; Neoplasms; Peptides, Cyclic; Porosity; Positron-Emission Tomography; Pyrroles; Silicon Dioxide; Sunitinib	2015

Article

Year

Hollow mesoporous silica nanoparticles for tumor vasculature targeting and PET image-guided drug delivery.

Nanomedicine (London, England), 2015, Volume: 10, Issue:8

Topics: Angiogenesis Inhibitors; Animals; Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Female; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Indoles; Mice, Nude; Nanoparticles; Neoplasms; Peptides, Cyclic; Porosity; Positron-Emission Tomography; Pyrroles; Silicon Dioxide; Sunitinib

2015